← Eichor
Condition: Active Refractory Rheumatoid Arthritis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Active Refractory Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07001956A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Phase 2 · 57 location(s) · Amgen · NCT06570798An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06946199
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.